Interventional Cardiology Devices | Market Insights | Europe (Part 2) | 2022
Despite the negative impact of the COVID-19 pandemic in the short term, the European market will grow slightly through 2030, driven by an expanding CAD patient pool, an increasing prevalence of complex lesions, and the emergence of specialized premium-priced technologies to diagnose and treat these complex CADs—such as next-generation DES, BRS, and intravascular imaging catheters and pressure guidewires—supporting revenues. These areas of growth will offset ASP declines due to intense price competition across all market segments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Europe, with market projections across an 11-year period.
